PMID: 31287557
Compounded GLP-1s are a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Wadysawa Andersa 38A, NIP: 9661999896, REGON: 200286562, entered in the register of entrepreneurs kept by the District Court in Biaystok, XII Economic Division of the National Court Register under KRS number 0000336091 with the share capital fully paid up in the amount of PLN 400,000.
Management strategies include: Taking the injection before bed so nausea occurs during sleep Starting at a lower dose and increasing gradually Taking an over-the-counter anti-nausea medication 30 minutes before injection (with physician approval) Eating a small, bland meal before injection Facial Flushing A warm, red flush across the face and sometimes the upper body is common shortly after injection
